Motif Bio PLC Annual Report and Accounts & Notice of AGM (3964Y)
09 September 2020 - 4:00PM
UK Regulatory
TIDMMTFB
RNS Number : 3964Y
Motif Bio PLC
09 September 2020
Motif Bio plc
("Motif Bio" or the "Company")
Annual Report and Accounts & Notice of AGM
Motif Bio plc (AIM: MTFB) confirms that the Annual Report and
Accounts for the year ended 31 December 2019, together with the
Notice of Annual General Meeting ('AGM'), Form of Proxy and, where
relevant, a letter notifying shareholders who have consented to
receiving electronic communications that the aforementioned
documents are available on the Company website, have been posted to
shareholders. The aforementioned documents, aside from the letter
to shareholders, are available to download from the Company's
website here: www.motifbio.com
The Company's AGM is to be held at 11am BST on 30 September 2020
at 201 Temple Chambers, 3-7 Temple Avenue, London, EC4Y 0DT, United
Kingdom.
Shareholders are strongly encouraged to vote on the resolutions
by proxy before the deadline of 11am BST on 28 September 2020.
For further information please contact:
ir@motifbio.com
Motif Bio plc
Jonathan Gold (President and Chief
Business Officer)
SP Angel Corporate Finance LLP (NOMAD
& BROKER) +44 (0) 20 3470 0470
David Hignell/Caroline Rowe (Corporate
Finance)
Vadim Alexandre/Abigail Wayne (Sales
& Broking)
Walbrook PR Ltd. (UK FINANCIAL PR
& IR) +44 (0) 20 7933 8780
Paul McManus/ Lianne Cawthorne motifbio@walbrookpr.com
Forward-Looking Statements
When used in this Press Release, the words or phrases "intends,"
"anticipates," "expected to be" or similar expressions are intended
to identify "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
are subject to certain risks and uncertainties including, but not
limited to, changes in economic conditions in the Company's market
area, changes in policies by regulatory agencies, fluctuations in
interest rates, competition that could cause actual results to
differ materially from historical earnings and those presently
anticipated or projected, and other risks described in the
Company's filings with the Securities and Exchange Commission. The
Company cautions readers not to place undue reliance on any such
forward-looking statements, which speak only as of the date made.
The Company advises readers that the factors listed above could
affect the Company's financial performance and could cause the
Company's actual results for future periods to differ materially
from any opinions or statements expressed with respect to future
periods in any current statements. The Company does not undertake,
and specifically disclaims any obligation, to publicly release the
result of any revision which may be made to any forward-looking
statements to reflect events or circumstances after the date of
such statements or to reflect the occurrence of anticipated or
unanticipated events.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCDVLFBBKLXBBV
(END) Dow Jones Newswires
September 09, 2020 02:00 ET (06:00 GMT)
Motif Bio (LSE:MTFB)
Historical Stock Chart
From Dec 2024 to Jan 2025
Motif Bio (LSE:MTFB)
Historical Stock Chart
From Jan 2024 to Jan 2025